Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism AKR1B1 inhibitors(Aldose reductase inhibitors), GcMAF inhibitors(Vitamin D-binding protein-macrophage activating factor inhibitors), α-glucosidase inhibitors(Acidic alpha-glucosidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Endocrinology and Metabolic Disease | Discovery | - | 26 Sep 2025 |





